Pepinemab(VX 15/2503) is a humanized IgG4 monoclonal antibody targeting sematone 4D. Pepinemab has anti-cancer activity and blocks the activity of SEMA4D, which is used to study degenerative diseases similar to Alzheimers disease.
CAS Number:
[2097151-87-4]
Target:
VX 15/2503
* VAT and and shipping costs not included. Errors and price changes excepted